ANDREAS MUHS

Chief Scientific Officer
cardiac stem cell
AC Immune
Switzerland

Business Expert Cardiology
Biography

 Prior to joining AC Immune, Dr. Muhs was responsible the development of the cardiac stem cell-based program to treat myocardial infarct patients, including worldwide pre-clinical program collaborations and technology transfers at ViaCell Inc., Cambridge, MA, for. Prior to ViaCell Inc. he held the position of Director of Pharmacology & Histology at Cardion AG where he developed research projects to clinical approaches in the fields of heart & circulation, angiogenesis, immunology, diabetes and toxicology with gene-, protein- and stem cell-based therapies. Dr. Muhs holds a PhD in Biology from the University Düsseldorf, Germany, where he worked on regulation of endothelial barrier functions.

Research Intrest

 heart & circulation, angiogenesis, immunology, diabetes and toxicology